
|Videos|January 30, 2012
Preventing Pneumococcal Disease
Advertisement
Populations at risk for developing pneumococcal disease, including seniors, can benefit from the preventive protection of vaccination. Many adults who are older than 65 years did not receive any vaccination against pneumococcal disease as a child. In addition, adults with comorbid conditions are at additional risk for developing pneumococcal infection, and should educate themselves on the benefits of vaccination for preventing potentially life-threatening illness.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Examining the Safety Profiles of SG and Pembrolizumab in ASCENT-04
2
FDA Accepts Furosemide Autoinjector sNDA for Treatment of Edema in Chronic Kidney Disease or Chronic Heart Failure
3
FDA Approves Pirtobrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia
4
Navigating the New Standard of Care: Patient Needs and the Pharmacist’s Critical Role in Perioperative MIBC Treatment
5


















































































































































































































